Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Contents: April 1 2002, Volume 1, Issue 6   [Index by Author]  [Cover Caption]
       Articles
       Minireviews
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

Petra Lindholm, Ulf Göransson, Senia Johansson, Per Claeson, Joachim Gullbo, Rolf Larsson, Lars Bohlin, and Anders Backlund
Cyclotides: A Novel Type of Cytotoxic Agents
Mol Cancer Ther 2002 1: 365-369. [Abstract] [Full Text] [PDF]  

Judith R. Kroep, Willem J. P. Loves, Clasina L. van der Wilt, Enrique Alvarez, Iannis Talianidis, Epie Boven, Boudewijn J. M. Braakhuis, Cornelis J. van Groeningen, Herbert M. Pinedo, and Godefridus J. Peters
Pretreatment Deoxycytidine Kinase Levels Predict in Vivo Gemcitabine Sensitivity
Mol Cancer Ther 2002 1: 371-376. [Abstract] [Full Text] [PDF]  

Saskia T. C. Neuteboom, Patricia L. Karjian, Christopher R. Boyer, Malgorzhata Beryt, Mark Pegram, Geoffrey M. Wahl, and H. Michael Shepard
Inhibition of Cell Growth by NB1011 Requires High Thymidylate Synthase Levels and Correlates with p53, p21, Bax, and GADD45 Induction
Mol Cancer Ther 2002 1: 377-384. [Abstract] [Full Text] [PDF]  

Gary K. Scott, Chloe Marden, Fan Xu, Liana Kirk, and Christopher C. Benz
Transcriptional Repression of ErbB2 by Histone Deacetylase Inhibitors Detected by a Genomically Integrated ErbB2 Promoter-reporting Cell Screen
Mol Cancer Ther 2002 1: 385-392. [Abstract] [Full Text] [PDF]  

Jung-Taek Yoon, Alexander F. Palazzo, Danhua Xiao, Thomas M. Delohery, Peter E. Warburton, Jeffrey N. Bruce, W. Joseph Thompson, Gerhard Sperl, Clark Whitehead, John Fetter, Rifat Pamukcu, Gregg G. Gundersen, and I. Bernard Weinstein
CP248, a Derivative of Exisulind, Causes Growth Inhibition, Mitotic Arrest, and Abnormalities in Microtubule Polymerization in Glioma Cells
Mol Cancer Ther 2002 1: 393-404. [Abstract] [Full Text] [PDF]  

Elizabeth K. Balcer-Kubiczek, George H. Harrison, Jing-Fan Xu, and Peter L. Gutierrez
Coordinate Late Expression of Trefoil Peptide Genes (pS2/TFF1 and ITF/TFF3) in Human Breast, Colon, and Gastric Tumor Cells Exposed to X-Rays
Mol Cancer Ther 2002 1: 405-415. [Abstract] [Full Text] [PDF]  

John D. Allen, Arnold van Loevezijn, Jeany M. Lakhai, Martin van der Valk, Olaf van Tellingen, Glen Reid, Jan H. M. Schellens, Gerrit-Jan Koomen, and Alfred H. Schinkel
Potent and Specific Inhibition of the Breast Cancer Resistance Protein Multidrug Transporter in Vitro and in Mouse Intestine by a Novel Analogue of Fumitremorgin C
Mol Cancer Ther 2002 1: 417-425. [Abstract] [Full Text] [PDF]  

Minireviews:

John D. Allen and Alfred H. Schinkel
Multidrug Resistance and Pharmacological Protection Mediated by the Breast Cancer Resistance Protein (BCRP/ABCG2)
Mol Cancer Ther 2002 1: 427-434. [Full Text] [PDF]  

Mack N. Barnes, Candace J. Coolidge, Akseli Hemminki, Ronald D. Alvarez, and David T. Curiel
Conditionally Replicative Adenoviruses for Ovarian Cancer Therapy
Mol Cancer Ther 2002 1: 435-439. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.